Company, Animal health
A significant milestone for Revatis: the company has enrolled its first clinical case using allogeneic muscle-derived stem cells, selected via a compatibility test developed in collaboration with Progenus and supported by published preclinical data.
This first application concerns immune-mediated keratitis in horses, drawing directly on recently published findings.
#ophtalmology #stemcells #horse #regenerativemedicine #cellandgenetherapy #immk